Antipsychotic adjunctive therapy to mood stabiliser should be continued for 6 months after remission of a manic episode

Comment

Kotaro Hatta. Evid Based Ment Health. 2017 Feb.

. 2017 Feb;20(1):28.

doi: 10.1136/eb-2016-102532. Epub 2016 Dec 30.

No abstract available

Conflict of interest statement

Competing interests: None declared.

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
Yatham LN, Beaulieu S, Schaffer A, Kauer-Sant'Anna M, Kapczinski F, Lafer B, Sharma V, Parikh SV, Daigneault A, Qian H, Bond DJ, Silverstone PH, Walji N, Milev R, Baruch P, da Cunha A, Quevedo J, Dias R, Kunz M, Young LT, Lam RW, Wong H. Yatham LN, et al. Mol Psychiatry. 2016 Aug;21(8):1050-6. doi: 10.1038/mp.2015.158. Epub 2015 Oct 13. Mol Psychiatry. 2016. PMID: 26460229 Free PMC article. Clinical Trial.

1. McLaren R, Cipriani A. Clinical guidelines for mood disorders: the roads travelled, the road ahead. Aust N Z J Psychiatry 2016;50:1123–4. 10.1177/0004867416676371 - DOI - PubMed
1. Goodwin GM, Haddad PM, Ferrier IN, et al. . Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2016;30:495–553. 10.1177/0269881116636545 - DOI - PMC - PubMed
1. Leucht S, Cipriani A, Spineli L, et al. . Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951–62. 10.1016/S0140-6736(13)60733-3 - DOI - PubMed
1. Cipriani A, Barbui C, Salanti G, et al. . Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011;378:1306–15. 10.1016/S0140-6736(11)60873-8 - DOI - PubMed
1. Ketter TA, Durgam S, Landbloom R, et al. . Long-term safety and tolerability of asenapine: a double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder. J Affect Disord 2017;207:384–92. 10.1016/j.jad.2016.09.037 - DOI - PubMed